Alaska Permanent Fund Corp Codiak Bio Sciences, Inc. Transaction History

Alaska Permanent Fund Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	BUY	$0.82 - $3.19 $803,759 - $3.13 Million	980,194 New	980,194 $767,000
Q2 2022 Aug 09, 2022	SELL	$2.24 - $6.96 $2.2 Million - $6.82 Million	-980,194 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$11.72 - $26.81 $7.58 Million - $17.3 Million	646,861 Added 194.06%	980,194 $18.2 Million
Q4 2020 Feb 05, 2021	BUY	$7.9 - $32.3 $2.63 Million - $10.8 Million	333,333 New	333,333 $10.8 Million

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of Alaska Permanent Fund Corp, based on Form 13F filings with the SEC.

Stay updated on Alaska Permanent Fund Corp with notifications on news.